NO950762L - Sulfaterte orer - Google Patents

Sulfaterte orer

Info

Publication number
NO950762L
NO950762L NO950762A NO950762A NO950762L NO 950762 L NO950762 L NO 950762L NO 950762 A NO950762 A NO 950762A NO 950762 A NO950762 A NO 950762A NO 950762 L NO950762 L NO 950762L
Authority
NO
Norway
Prior art keywords
sulfated
integer
ores
independently
selectin
Prior art date
Application number
NO950762A
Other languages
English (en)
Other versions
NO950762D0 (no
Inventor
Jacques Banville
Alain Martel
Alejandro A Aruffo
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO950762D0 publication Critical patent/NO950762D0/no
Publication of NO950762L publication Critical patent/NO950762L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Sulfaterte p-glykolipidforbindelser med formelen R40. OR« tfO NHR OR" hvor R er en acylrest av en fettsyre, R er -(CH=CH)m-(CH2)n-CH3, R2, R3, R4 og R6 er uavhengig av hverandre minst to -S03H, R2, R3, R4, R5 og R^ er hver uavhengig av hverandre hydrogen, usubstituert eller sub- stituert alkanoyl, arylalkyl eller arylkarbonyl hvor sub- stituenten er valgt blant halogen, Cj__4~alkyl, trifluor- metyl, hydroksy og C^-alkoksy, eller R4 og R6 er sammen benzyliden, eller R3 og R6 er sammen isopropyliden, m er et helt tall O eller l, n er et helt tall fra 5-14 inklusive, eller et ikke-toksisk, farmasøytisk akseptabelt salt, solvat eller hydrat derav som er inhibitorer av selectinforårsaket celleadhesjon og som er anvendelige til behandling eller hindring av betennelsessykdommer og andre patologiske tilstander i pattedyr.
NO950762A 1994-03-04 1995-02-28 Sulfaterte orer NO950762L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20606794A 1994-03-04 1994-03-04

Publications (2)

Publication Number Publication Date
NO950762D0 NO950762D0 (no) 1995-02-28
NO950762L true NO950762L (no) 1995-09-05

Family

ID=22764838

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950762A NO950762L (no) 1994-03-04 1995-02-28 Sulfaterte orer

Country Status (14)

Country Link
US (1) US5565433A (no)
EP (1) EP0671406A3 (no)
JP (1) JPH07285985A (no)
KR (1) KR950032259A (no)
CN (1) CN1111638A (no)
AU (1) AU1360495A (no)
CA (1) CA2142153A1 (no)
FI (1) FI951002A (no)
HU (1) HUT70433A (no)
IL (1) IL112734A0 (no)
NO (1) NO950762L (no)
PL (1) PL307523A1 (no)
RU (1) RU95103099A (no)
ZA (1) ZA951144B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935598A (en) * 1996-06-19 1999-08-10 Becton Dickinson Research Center Iontophoretic delivery of cell adhesion inhibitors
DE19700774A1 (de) * 1997-01-13 1998-07-16 Hoechst Ag Antiadhäsive Sulfatid-Mimetika
KR100880063B1 (ko) * 2001-08-16 2009-01-22 아스비오파마 가부시키가이샤 신규한 당지질 및 이것을 유효성분으로 하는 자기면역질환 치료약
CN100469784C (zh) * 2001-11-21 2009-03-18 奥尔胡斯大学 甘油一酯和甘油二酯糖苷作为抗炎药物的用途
WO2007038785A1 (en) * 2005-09-29 2007-04-05 Torrey Pines Institute For Molecular Studies Sulfatides for treatment of autoimmune disorders
US20110118197A1 (en) * 2005-09-29 2011-05-19 Vipin Kumar Chaturvedi Prevention of hepatic ischemic reperfusion injury by administration of sulfatides
US9181292B2 (en) 2011-01-05 2015-11-10 Pi-Hui Liang Methods for preparation of glycosphingolipids and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1164388A (en) * 1966-06-14 1969-09-17 Shionogi & Co Crystalline Sulfur-Containing Glycolipid and the Production Thereof.
EP0146810A3 (de) * 1983-12-05 1987-05-13 Solco Basel AG Verfahren zur Herstellung von Sphingosinderivaten
EP0212400B1 (de) * 1985-08-13 1992-01-02 Solco Basel AG Neues Verfahren zur Herstellung von Sphingosinderivaten
JPH0317020A (ja) * 1989-06-14 1991-01-25 Nippon Koutai Kenkyusho:Kk 抗ｈｉｖ剤
ATE224911T1 (de) * 1990-07-17 2002-10-15 Univ Oklahoma Gmp-140 ligand
US5211937A (en) * 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
DK84691D0 (da) * 1991-05-07 1991-05-07 Karsten Buschard Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
WO1993005803A1 (en) * 1991-09-25 1993-04-01 Genetics Institute, Inc. Anti-inflammatory selectin inhibitors
US5326752A (en) * 1991-11-27 1994-07-05 Glycomed Incorporated Substituted lactose and lactosamine derivatives as cell adhesion inhibitors

Also Published As

Publication number Publication date
KR950032259A (ko) 1995-12-20
HUT70433A (en) 1995-10-30
CA2142153A1 (en) 1995-09-05
RU95103099A (ru) 1997-03-20
JPH07285985A (ja) 1995-10-31
EP0671406A3 (en) 1995-11-08
NO950762D0 (no) 1995-02-28
CN1111638A (zh) 1995-11-15
HU9500656D0 (en) 1995-04-28
EP0671406A2 (en) 1995-09-13
ZA951144B (en) 1996-08-13
AU1360495A (en) 1995-09-14
FI951002A0 (fi) 1995-03-03
PL307523A1 (en) 1995-09-18
US5565433A (en) 1996-10-15
IL112734A0 (en) 1995-05-26
FI951002A (fi) 1995-09-05

Similar Documents

Publication Publication Date Title
NO950763L (no) Sulfaterte orer
PE99298A1 (es) Oligosacaridos modificados
BG100951A (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
SK279214B6 (sk) Zlúčeniny indolu, spôsob ich prípravy, farmaceutic
HK1020194A1 (en) Crystals of benzimidazole derivatives and their production
GR3032629T3 (en) Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation
WO2003084937A3 (en) Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
ZA846093B (en) Heptaose compounds,preparation and use thereof
NO950762L (no) Sulfaterte orer
AU1404988A (en) New amino-5,6,7,8-tetrahydronaphto(2,3-b)furan derivatives, the processes for preparing them and the pharmaceutical compositions which contain them
NO990335L (no) Arylsykloalkankarboksylestere, anvendelse derav, farmas°ytiske sammensetninger og fremstilling
TW363891B (en) Aminoalkyl and acylaminoalkyl ethers, process for their preparation, and their use as bradykinin receptor
NO985040L (no) FremgangsmÕte for inhibering av vaskulµrcelleadhesjonsmolekyl-1 og behandling av kroniske, inflammatoriske sykdommer med 2,6-dialkyl-4-silylfenoler
ES520860A0 (es) Procedimiento de preparar teofilinas 7-substituidas.
TW350838B (en) Quinoline derivatives
ZA833190B (en) Benzoxazin compounds,processes for their preparation,and pharmaceutical compositions thereof
ES8304140A1 (es) Procedimiento para preparar derivados de cefalosporina.
AU5674894A (en) Azanoradamantanes
DE3175674D1 (en) Novel dibenzoxepins, their preparation, compositions containing them and the use of dibenzoxepins in the treatment of allergic conditions
GR3026532T3 (en) Indole derivatives as 5ht1-like agonists
NO970329L (no) Tetracykliske triterpener
DE3662048D1 (de) Novel thyronine derivatives
CS654584A2 (en) Zpusob pripravy diazinethenylfenyloxamove kyseliny
ATE156487T1 (de) Mercapto-acetamid-derivate
DE3372963D1 (en) Novel aminonaphthacene derivatives and process for preparation thereof